DE3363563D1 - Medicines containing an association of at least one immunotoxine and at least one monovalent carboxylic ionophore - Google Patents

Medicines containing an association of at least one immunotoxine and at least one monovalent carboxylic ionophore

Info

Publication number
DE3363563D1
DE3363563D1 DE8383400233T DE3363563T DE3363563D1 DE 3363563 D1 DE3363563 D1 DE 3363563D1 DE 8383400233 T DE8383400233 T DE 8383400233T DE 3363563 T DE3363563 T DE 3363563T DE 3363563 D1 DE3363563 D1 DE 3363563D1
Authority
DE
Germany
Prior art keywords
association
immunotoxine
monovalent carboxylic
medicines containing
carboxylic ionophore
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383400233T
Other languages
German (de)
English (en)
Inventor
Franz Jansen
Pierre Gros
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of DE3363563D1 publication Critical patent/DE3363563D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8383400233T 1982-02-09 1983-02-04 Medicines containing an association of at least one immunotoxine and at least one monovalent carboxylic ionophore Expired DE3363563D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8202091A FR2521010B1 (fr) 1982-02-09 1982-02-09 Medicaments comportant en tant qu'association au moins une immunotoxine et au moins un ionophore carboxylique monovalent

Publications (1)

Publication Number Publication Date
DE3363563D1 true DE3363563D1 (en) 1986-06-26

Family

ID=9270809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383400233T Expired DE3363563D1 (en) 1982-02-09 1983-02-04 Medicines containing an association of at least one immunotoxine and at least one monovalent carboxylic ionophore

Country Status (8)

Country Link
US (1) US4767621A (OSRAM)
EP (1) EP0086152B1 (OSRAM)
JP (1) JPS59500272A (OSRAM)
AT (1) ATE19857T1 (OSRAM)
DE (1) DE3363563D1 (OSRAM)
FR (1) FR2521010B1 (OSRAM)
NO (1) NO833641L (OSRAM)
WO (1) WO1983002725A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2516794B1 (fr) * 1981-11-20 1985-10-25 Sanofi Sa Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique
CA1314245C (en) * 1984-05-23 1993-03-09 Franz Jansen Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators
FR2564839B1 (fr) * 1984-05-23 1986-11-14 Sanofi Sa Conjugues associant par liaison covalente un ionophore carboxylique monovalent et une macromolecule et leur utilisation comme agents potentialisateurs des immunotoxines
FR2573656B1 (fr) * 1984-11-29 1987-02-27 Sanofi Sa Medicament comportant en tant qu'association au moins une immunotoxine et au moins un polymere contenant du mannose
IL116559A (en) * 1995-11-17 2005-11-20 Yissum Res Dev Co Chimeric protein consisting of a bacterial toxin and a myelin basic protein sequence
US20190046497A1 (en) * 2016-02-14 2019-02-14 Yeda Research And Development Co., Ltd. Methods of modulating protein exocytosis and uses of same in therapy

Also Published As

Publication number Publication date
EP0086152A1 (fr) 1983-08-17
ATE19857T1 (de) 1986-06-15
JPH0534343B2 (OSRAM) 1993-05-21
FR2521010A1 (fr) 1983-08-12
FR2521010B1 (fr) 1985-07-19
WO1983002725A1 (fr) 1983-08-18
JPS59500272A (ja) 1984-02-23
NO833641L (no) 1983-10-06
US4767621A (en) 1988-08-30
EP0086152B1 (fr) 1986-05-21

Similar Documents

Publication Publication Date Title
EP0112852A4 (en) PHARMACEUTICAL GEL COMPOSITION.
JPS5791983A (en) Ranitidine, manufacture and medicinal composition containing same
NO154995C (no) Flaske med skrukapsel.
IL69438A (en) Phenethanolamines,their manufacture and pharmaceutical compositions containing them
DE3377134D1 (en) Polysaccharide concentrates, process for their preparation and medicinal and cosmetic compositions containing them
NL990010I1 (nl) Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze derivaten bevatten.
IL63801A0 (en) 2-amino-3-carbethoxyamino-6-(p-fluorobenzylamino)-pyridine-maleate,its production and pharmaceutical compositions containing it
IL68804A0 (en) Amides,their manufacture and pharmaceutical compositions containing them
IL61930A (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it
IT8220758A0 (it) Prodotti farmaceutici informa-ritardo e procedimento per ottenerli.
ES523104A0 (es) Dispositivo empujador de producto.
PH21355A (en) Pharmaceutical combination composition and associated method
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
PH16982A (en) Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide and its pharmaceutical composition
IL68576A0 (en) Azepinoindoles,their production and pharmaceutical compositions containing them
JPS57181060A (en) Imidazole derivatives, manufacture and medicinal composition containing them
IL67284A (en) N-substituted-2-pyridylindoles,their manufacture and pharmaceutical compositions containing them
DE3468325D1 (en) Cytotoxic pharmaceutical association, especially suited for the treatment of cancers
IT8348862A0 (it) Interferon-alfa 6l, composizioni farmaceutiche che lo contengono eprocedimento per la loro preparazione
FR2521010B1 (fr) Medicaments comportant en tant qu'association au moins une immunotoxine et au moins un ionophore carboxylique monovalent
JPS57102877A (en) Aminocyclopentanone amides, manufacture and drug composition
ATE20519T1 (de) Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und chloroquin.
PH18734A (en) Panthenol derivatives and their pharmaceutical composition
DE3164704D1 (en) Carbamoyloxyamino-1,4-benzodiazepines, their preparation and medicines containing them
JPS57159766A (en) Anorexic substituted trifluoromethylphenyl- tetrahydropyridines, manufacture and pharmaceutical composition

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee